drugset / Trial / NCT05454358
Letrozole as Maintenance Therapy for Post-surgical Endometrial Cancer Patients With NSMP
Phase 2/3
Terminated
12 enrolled
Fudan University
Obstetrics & Gynecology Hospital of Fudan University · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Aim to investigate the effect of Letrozole as maintenance after adjuvant treatment on the prognosis of post-operative endometrial cancer patients with non-specific molecular profile.
Timeline
- Start
- 2022-08-02
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Letrozole | Other / unclassified | 0.5 mg | Oral |